(Q33877162)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

matrix-assisted laser desorption/ionization

29 January 2020

main subject

0 references

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

V Popescu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

M J A Koel-Simmelink

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

T V Pham

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

J C Knol

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

M Khalil

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

J Killestein

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

J Nielsen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

H Vrenken

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

C D Dijkstra

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

C R Jimenez

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

C E Teunissen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

19 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

838-850

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

Biological markers in CSF and blood for axonal degeneration in multiple sclerosis

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Biomarker research in multiple sclerosis: addressing axonal damage and heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Proteomic analysis of multiple sclerosis cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Cerebrospinal fluid proteome profile in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Quantitative matrix-assisted laser desorption ionization-fourier transform ion cyclotron resonance (MALDI-FT-ICR) peptide profiling and identification of multiple-sclerosis-related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Measuring brain atrophy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Black holes in multiple sclerosis: definition, evolution, and clinical correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Support vector machine approach to separate control and breast cancer serum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Complement in multiple sclerosis: its role in disease and potential as a biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Comprehensive analysis of short peptides in sera from patients with IgA nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

High-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

The chromogranin-secretogranin family

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldtâ Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511399614

21 January 2018

Identifiers

DOI

10.1177/1352458511399614

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505015%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference